2 DOSAGE AND ADMINISTRATION Administer intravenously only after dilution or admixing in a larger volume of fluid. 4 mEq/mL). 4 ) Monitor serum phosphorus, potassium, calcium and magnesium concentrations. 4 ) See full prescribing information for instructions on preparation and administration.
3 ) Recommended Dosage for Correction of Hypophosphatemia in Intravenous Fluids Potassium phosphates injection is only for administration to a patient with a serum potassium concentration less than 4 mEq/dL; otherwise, use an alternative source of phosphorus.
1 ) The dosage is dependent upon the individual needs of the patient and the contribution of phosphorus and potassium from other sources. 2 ) See full prescribing information for recommendations on initial or single dosing, repeated dosing, concentration and infusion rate.
2 ) Recommended Dosage for Administration in Parenteral Nutrition Individualize the dosage based upon the patient’s clinical condition, nutritional requirements and the contribution of oral or enteral phosphorus and potassium intake.
4 ) See full prescribing information for recommendations for daily and maximum dosage. 1 Preparation and Administration in Intravenous Fluids to Correct Hypophosphatemia Preparation Potassium phosphates injection is for intravenous infusion into a central or peripheral vein only after dilution .
9% Sodium Chloride Injection, USP (normal saline) or 5% Dextrose Injection, USP (D5W). For adults and pediatric patients 12 years of age and older a total volume of 100 mL or 250 mL is recommended. For pediatric patients less than 12 years of age, use the smallest recommended volume, considering daily fluid requirements and the maximum concentration for peripheral and central administration shown in Table 1.
The concentration of the diluted solution should take into consideration the age of the patient, the amounts of phosphorus and potassium in the dose and is dependent upon whether administration will be through a peripheral or central venous catheter.
The recommended maximum concentrations are shown in Table 1:
Table 1: Maximum Recommended Concentration of Potassium Phosphates Injection by Age and Route of Administration (Peripheral vs. 8 mEq/10 mL) Visually inspect the solution for particulate matter and discoloration before and after dilution and prior to administration.
Do not administer unless solution is clear and seal on the vial is intact. Administration Check serum potassium and calcium concentrations prior to administration. 4) ] . 3) ] . If the potassium concentration is 4 mEq/dL or more, use an alternative source of phosphorus.
4) ] . 2) ] . Storage and Stability Single-Dose Vial (15 mL) For single use only. Discard used vial, including any unused contents. After dilution, the solution is stable for a maximum of 4 hours at room temperature 20° to 25°C (68° to 77°F) or 14 days under refrigeration at 2° to 8°C (36° to 46°F).
4 mEq/mL). The dosage is dependent upon the individual needs of the patient and the contribution of phosphorus and potassium from other sources. Initial or Single-Dose The phosphorus doses in Table 2 are general recommendations for an initial or single-dose and are intended for most patients.
Based upon clinical requirements, some patients may require a lower or higher dose. 1) ] . 6) ] . Monitor serum phosphorus, potassium, calcium and magnesium serum concentrations. 5 mg/dL as the lower end of the reference range for healthy adults and pediatric patients 12 months of age and older.
Serum phosphorus reported using 4 mg/dL as the lower end of the reference range for preterm and term infants less than 12 months of age. Serum phosphorus concentrations may vary depending on the assay used and the laboratory reference range.
b Weight is in terms of actual body weight. Limited information is available regarding dosing of patients significantly above ideal body weight; consider using an adjusted body weight for these patients. c up to a maximum of phosphorus 45 mmol (potassium 66 mEq) as a single-dose.
1) ] and the infusion rate is dependent upon whether administration will be through a peripheral or central venous catheter. The maximum recommended infusion rates are shown in Table 3 for adults and pediatric patients 12 years of age and older.
8 mmol/hour (potassium 10 mEq/hour) Central Venous Catheter phosphorus 15 mmol/hour (potassium 22 mEq/hour) Continuous electrocardiographic (ECG) monitoring and infusion through a central venous catheter is recommended for infusion rates higher than: Potassium 10 mEq/hour for adults and pediatric patients weighing 20 kg or greater.
5 mEq/kg/hour for pediatric patients weighing less than 20 kg. Repeated Dosing Additional dose(s) following the initial dose may be needed in some patients. Prior to administration of additional doses, assess the patient clinically, obtain serum phosphorus, calcium and potassium concentrations and adjust the dose accordingly.
3 Preparation and Administration in Parenteral Nutrition Potassium phosphates injection is for intravenous infusion into a peripheral or central vein only after dilution and admixing . Potassium phosphates injection is to be prepared only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area).
The key factor in the preparation is careful aseptic technique to avoid inadvertent touch contamination during mixing of solutions and addition of other nutrients. Transfer the required amount of potassium phosphates injection to the parenteral nutrition solution following the admixture of amino acids, dextrose, electrolytes solutions and prior to lipids (if added).
Because additives may be incompatible, evaluate all additions to the parenteral nutrition container for compatibility and stability of the resulting preparation. Calcium and phosphate ratios must be considered. 2) ] . Calcium-phosphate stability in parenteral nutrition solutions is dependent upon the pH of the solution, temperature and relative concentration of each ion.
Discard if any precipitates are observed. Inspect the final parenteral solution containing potassium phosphates injection to ensure that: precipitates have not formed during mixing or addition of additives and inspect again before administration.
the emulsion has not separated, if lipids have been added. Separation of the emulsion can be visibly identified by a yellowish streaking or the accumulation of yellowish droplets in the admixed emulsion. The final parenteral nutrition solution is for intravenous infusion into a peripheral or central vein.
The choice of a peripheral or central venous route should depend on the osmolarity of the final infusate. 7) ] . Storage Protect the parenteral nutrition solution from light during storage. Stability Single-Dose Vial (15 mL) For single use only.
Discard used vial, including any unused contents. Use parenteral nutrition solution containing potassium phosphates injection promptly after mixing. Any storage of the admixture should be under refrigeration from 2° to 8°C (36° to 46°F) and limited to a brief period of time, no longer than 24 hours.
After removal from refrigeration, bring to room temperature and use promptly and complete the infusion within 24 hours. Discard any remaining admixture. 4 mEq/mL). The recommended daily dosage in parenteral nutrition is shown in Table 4.
Individualize the dosage based upon the patient’s clinical condition, nutritional requirements and the contribution of oral or enteral phosphorus and potassium intake. The amount of phosphorus that can be added to parenteral nutrition may be limited by the amount of calcium that is also added to the solution.
73 m 2 ), start at the low end of the dosage range. Monitoring Monitor serum phosphorus, potassium, calcium and magnesium concentrations and adjust the dosage accordingly.